by admin | Oct 18, 2023 | Pharma
There is still some way until India’s dependence on imports of active pharmaceutical ingredients (APIs) and intermediates from China reduces, but the growth rate of imports has come down. While the production-linked incentive (PLI) scheme for bulk drugs (APIs) has...
